CAM
YARW

Cormorant Asset Management’s Yarrow Bioscience YARW Stock Holding History

Cormorant Asset Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27,419
Closed -$2.26M – 43
2025
Q2 		$2.26M Buy
+27,419
New +$1.78M 0.17% 41
2025
Q1 		– Sell
-27,887
Closed -$4.67M – 50
2024
Q4 		$4.67M Hold
27,887
– – 0.26% 38
2024
Q3 		$2.62M Hold
27,887
– – 0.14% 42
2024
Q2 		$2.75M Hold
27,887
– – 0.16% 46
2024
Q1 		$4.28M Hold
27,887
– – 0.19% 56
2023
Q4 		$3.25M Buy
+27,887
New +$4.35M 0.16% 46
2018
Q2 		– Sell
-94
Closed -$12.7M – 61
2018
Q1 		$12.7M Buy
+94
New +$11.4M 0.94% 25

Other funds holding YARW

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Cormorant Asset Management's YARW Position: Q3 2025 in Review

Cormorant Asset Management sold out of Yarrow Bioscience (YARW) in Q3 2025, closing a stake of 27,419 shares — an estimated $2.26M sold.

Cormorant Asset Management first reported a position in YARW in Q1 2018 and held it in 7 quarters. The position peaked at $12.7M in Q1 2018. 34 funds tracked by Wall St. Rank hold YARW as of Q3 2025.

  • Cormorant Asset Management reported no remaining Yarrow Bioscience position as of Q3 2025 after selling out during the quarter.
  • Cormorant Asset Management sold 27,419 Yarrow Bioscience shares in Q3 2025, an estimated $2.26M.
  • Cormorant Asset Management first reported a position in Yarrow Bioscience in Q1 2018 and held it in 7 quarters.
  • Cormorant Asset Management's Yarrow Bioscience position peaked at $12.7M in Q1 2018.
  • 34 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2025.

Based on Cormorant Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.